comparemela.com

Latest Breaking News On - Nektar therapeutics daily - Page 5 : comparemela.com

Nektar Therapeutics (NKTR) Scheduled to Post Earnings on Tuesday

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) will be posting its quarterly earnings results after the market closes on Tuesday, November 7th. Analysts expect Nektar Therapeutics to post earnings of ($0.18) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link. Nektar […]

United-states
Verition-fund-management
Syntax-advisors
Halbert-hargrove-global-advisors
Life-insurance-co
Nektar-therapeutics-company-profile
Nektar-therapeutics
Get-free-report
Fund-management
Hargrove-global-advisors
Financial-advocates-investment-management

Analysts Set Expectations for Nektar Therapeutics' FY2023 Earnings (NASDAQ:NKTR)

Analysts Set Expectations for Nektar Therapeutics' FY2023 Earnings (NASDAQ:NKTR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Monaco
Zacks-research
Acadian-asset-management
Nektar-therapeutics
Blackrock-inc
Free-report
Nektar-therapeutic
Get-free-report
Track-capital
Asset-management

Nektar Therapeutics (NASDAQ:NKTR) Receives $3.00 Average Target Price from Analysts

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been given a consensus rating of “Reduce” by the five analysts that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the company. The average 12 month price target among […]

United-states
Envestnet-asset-management-inc
Tower-research-capital
Nektar-therapeutics
Life-insurance-co
Syntax-advisors
Get-free-report
Advocates-investment-management
Research-capital
Envestnet-asset-management
Therapeutics-stock-down

Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Price Target at $3.00

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received a consensus rating of “Reduce” from the five brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation and four have issued a hold recommendation on the company. The average twelve-month target price among brokers that […]

United-states
Vanguard-group-inc
York-mellon-corp
Nektar-therapeutics
Commonwealth-of-pennsylvania-public-school-empls-retrmt
Dimensional-fund-advisors
Get-free-report
Marketbeat-ratings
Therapeutics-stock-down
New-york-mellon-corp
Pennsylvania-public-school-empls-retrmt

Howard W. Robin Sells 19,998 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Howard W. Robin Sells 19,998 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Howardw-robin
Securities-exchange-commission
York-mellon-corp
Commonwealth-of-pennsylvania-public-school-empls-retrmt
Nasdaq
Dimensional-fund-advisors
Vanguard-group-inc
Jefferies-financial-group
Nektar-therapeutics
Get-free-report

vimarsana © 2020. All Rights Reserved.